Credit: Getty Images. Tecarfarin is a novel oral vitamin K antagonist with a similar mechanism of action to warfarin, though it is metabolized differently. The Food and Drug Administration (FDA) has ...

Anticoagulant treatments are crucial for managing many conditions, such as heart disease, stroke and venous thrombosis. Current options, however, carry an inherent risk of serious bleeding due to ...

KRASNOYARSK, Russia, 7th April, 2026 (WAM) -- Russian scientists have modified a polysaccharide derived from spruce wood, enhancing its ability to prevent blood clotting and neutralise free radicals, ...